Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sarah E Taylor
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
189 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Center-Metro Medical Center Bayamon
Bayamón, Puerto Rico
- Puerto Rico Hematology Oncology Group
Bayamón, Puerto Rico
- Hima San Pablo Oncologic Hospital
Caguas, Puerto Rico
- Doctors Cancer Center
Manati, Puerto Rico
- Instituto Oncologia Moderna Ponce
Ponce, Puerto Rico
- Centro Comprensivo de Cancer de Upr
San Juan, Puerto Rico
- Proncology
San Juan, Puerto Rico
- Primary Care Physician Group
San Juan, Puerto Rico
- San Juan City Hospital
San Juan, Puerto Rico
- San Juan Community Oncology Group
San Juan, Puerto Rico
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- University of Arizona Cancer Center-Orange Grove Campus
Tucson, Arizona, United States
- Mercy Hospital Fort Smith
Fort Smith, Arkansas, United States
- Carti Cancer Center
Little Rock, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Uc San Diego Health System - Encinitas
Encinitas, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Uc San Diego Medical Center - Hillcrest
San Diego, California, United States
- Uchealth University of Colorado Hospital
Aurora, Colorado, United States
- Cancer Care and Hematology-Fort Collins
Fort Collins, Colorado, United States
- Poudre Valley Hospital
Fort Collins, Colorado, United States
- Uchealth Greeley Hospital
Greeley, Colorado, United States
- Medical Center of the Rockies
Loveland, Colorado, United States
- Hartford Hospital
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
- Emory University Hospital Midtown
Atlanta, Georgia, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- Lewis Cancer and Research Pavilion at Saint Joseph'S/candler
Savannah, Georgia, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Saint Alphonsus Cancer Care Center-Caldwell
Caldwell, Idaho, United States
- Kootenai Health - Coeur D'Alene
Coeur d'Alene, Idaho, United States
- Walter Knox Memorial Hospital
Emmett, Idaho, United States
- Idaho Urologic Institute-Meridian
Meridian, Idaho, United States
- Saint Alphonsus Cancer Care Center-Nampa
Nampa, Idaho, United States
- Kootenai Clinic Cancer Services - Post Falls
Post Falls, Idaho, United States
- Kootenai Clinic Cancer Services - Sandpoint
Sandpoint, Idaho, United States
- Osf Saint Anthony'S Health Center
Alton, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Jan 2020
- Primary completion
- 6 Feb 2027
- Completion
- 6 Feb 2028
- Last update posted
- 27 Mar 2026
- Registered enrollment
- 318
- Registry id
- NCT03997370
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.